Related Experiment Video
Updated: May 19, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Tuberculosis in children exposed at home to multidrug-resistant tuberculosis
Mercedes C Becerra1, Molly F Franke, Sasha C Appleton
1Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA. mbecerra@post.harvard.edu
Insights
Children exposed to multidrug-resistant tuberculosis (MDR-TB) face a high risk of developing TB disease, especially in the first year after diagnosis of an infectious household member. This underscores the urgent need for pediatric contact investigations and prompt treatment.
Area of Science:
- Public Health
- Infectious Diseases
- Pediatrics
Background:
- The global burden of tuberculosis (TB) in children exposed to multidrug-resistant tuberculosis (MDR-TB) within households remains largely unquantified.
- Millions of children worldwide are chronically exposed to infectious MDR-TB patients due to limited treatment access.
Purpose of the Study:
- To quantify the burden of TB disease among child household contacts of MDR-TB patients.
- To estimate the prevalence and incidence of TB disease in children exposed to MDR-TB.
Main Methods:
- A retrospective cohort study was conducted in Lima, Peru, from 1996 to 2003.
- Included child and adult household contacts of patients treated for MDR-TB.
- Primary outcome was TB disease, with prevalence estimated at index case treatment start and incidence tracked over 4 years.
Main Results:
- Among 1299 child contacts, TB prevalence was 1771 per 100,000 children.
- TB incidence was highest in the first year (2079 per 100,000 child-years), remaining elevated over 4 years.
- Child contacts exhibited TB disease rates approximately 30 times higher than the general pediatric population, with 20% of TB cases occurring in children.
Conclusions:
- Children exposed to MDR-TB patients face a significant risk of TB disease at the time of diagnosis and in the subsequent year.
- Highlights the critical need for contact investigations and timely referral/treatment systems for pediatric household contacts of MDR-TB patients.
- Recommendations apply regardless of the child's age, emphasizing universal screening and care.
Background:
The tuberculosis burden in children exposed at home to multidrug-resistant tuberculosis (MDR-TB) is unquantified. With limited access to MDR-TB treatment, likely millions of children share the experience of chronic exposure to an infectious patient.
Methods:
We conducted a retrospective cohort study of child and adult household contacts of patients treated for MDR-TB in Lima, Peru, in 1996 to 2003. The primary outcome was TB disease. We estimated prevalence of TB disease when the index case began MDR-TB treatment and incidence of TB disease over the subsequent 4 years.
Results:
Among 1299 child contacts, 67 were treated for TB. TB prevalence was 1771 (confidence interval [CI]: 1052-2489) per 100,000 children. In 4362 child-years of follow-up, TB incidence rates per 100,000 child-years were: 2079 (CI: 1302-2855) in year 1; 315 (CI: 6-624) in year 2; 634 (CI: 195-1072) in year 3; and 530 (CI: 66-994) in year 4. TB disease rates in children aged >1 year were not significantly different from those observed in adults. Children accounted for 20% of TB cases. Seven (87.5%) of 8 children tested had MDR-TB. Child contacts had TB disease rates approximately 30 times higher than children in the general population.
Conclusions:
Children were at high risk for TB disease when the index case started MDR-TB treatment and during the following year. These results highlight the need for implementing contact investigations and establishing systems for prompt referral and treatment of pediatric household contacts of MDR-TB patients, regardless of the age of the child.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pharmacokinetics in Pediatric Patients: Drug Excretion
